Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × niraparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 9 Prostatic Neoplasms 6 Neoplasm Metastasis 5 Breast Neoplasms 5 Neoplasms 4 Fallopian Tube Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Prostatic Neoplasms, Castration-Resistant 2 Glioma 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Castration-sensitive Prostate Cancer 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡